Intranasal Oxytocin (TI-001) Trial Investigates High Frequency Episodic and Chronic Migraine
TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
Abstract
A randomized clinical trial evaluated intranasal oxytocin (TI-001) for treating high frequency episodic and chronic migraine.
